S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies, such as trastuzumab, can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Colony-stimulating factors, such as filgrastim, may help a person's immune system recover from the side effects of chemotherapy. PURPOSE: Phase II trial to study the effectiveness of combining trastuzumab with docetaxel, vinorelbine, and filgrastim in treating women who have stage IV breast cancer.
Key facts
- Study ID
- NCT00041067
- Run by
- SWOG Cancer Research Network
- People needed
- 76
- Starts
- 2002-09-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2013-06-06
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center — Fort Smith, Arkansas, United States
- Ben E. Owens Cancer Treatment Center at St. Bernard's Medical Center — Jonesboro, Arkansas, United States
- Eden Medical Center — Castro Valley, California, United States
- Saint Rose Hospital — Hayward, California, United States
- Highland General Hospital at St. George's University School of Medicine — Oakland, California, United States
- Alta Bates Summit Medical Center - Summit Campus — Oakland, California, United States
- CCOP - Bay Area Tumor Institute — Oakland, California, United States
- Valley Care Medical Center — Pleasanton, California, United States
- University of California Davis Cancer Center — Sacramento, California, United States
- Mercy General Hospital — Sacramento, California, United States
- Doctors Medical Center - San Pablo Campus — San Pablo, California, United States
- West Florida Cancer Institute at West Florida Hospital - Pensacola — Pensacola, Florida, United States
- St. Luke's Mountain States Tumor Institute - Boise — Boise, Idaho, United States
- Saint Anthony's Hospital at Saint Anthony's Health Center — Alton, Illinois, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States
- Good Samaritan Regional Health Center — Mount Vernon, Illinois, United States
- Edward Hospital Cancer Center — Naperville, Illinois, United States
- Hematology Oncology Consultants - Naperville — Naperville, Illinois, United States
- Cancer Center of Kansas, PA - Chanute — Chanute, Kansas, United States
- Cancer Center of Kansas, PA - Dodge City — Dodge City, Kansas, United States
- Cancer Center of Kansas, PA - El Dorado — El Dorado, Kansas, United States
- Cancer Center of Kansas, PA - Kingman — Kingman, Kansas, United States
- Southwest Medical Center — Liberal, Kansas, United States
- Cancer Center of Kansas, PA - Newton — Newton, Kansas, United States
- Mobile Infirmary Medical Center — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.